Predictive Oncology (POAI) Corporate Media Kit

commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commer- cialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK. Arlette H. Uihlein, MD, FCAP, FASCP Vice President, Operations, Pathology Services & Medical Director, Helomics Dr. Arlette Uihlein serves as the Vice President Pathology Services and Medical Director of Helomics®. Dr. Uihlein is Board Certified in Anatomic and Clinical Pathology, Cytopathology and FamilyMedicine. Dr. Uihlein completed her Pathology Residency at Allegheny General Hospital, where she served as Chief Resident in Pathology and com- pleted Fellowships in Cytopathology and Surgical Pathology. She has conducted extensive clinical research involving molecular markers and imaging in solid tumors, and novel applications of cellular tumor markers. Dr. Uihlein received her B.S. from Baldwin-Wallace College and her Doctor of Medicine degree fromThe Medical College of Ohio. She is a Designated Civil Surgeon for the U.S. Dept. of Justice and a certified Medical ReviewOfficer for the Department of Transportation. She is a Fellow of the College of American Pathologists and the American Society of Clinical Pathology, NYSDOH Certificate Qualified, and a member of ASCO.